General Information of the Compound
Compound ID
CP0071651
Compound Name
4-[[4-(4-benzyl-1H-pyrazol-5-yl)piperidin-1-yl]methyl]pyridine
    Show/Hide
Structure
Formula
C21H24N4
Molecular Weight
332.451
Canonical SMILES
C(N1CCC(CC1)c1[nH]ncc1Cc1ccccc1)c1ccncc1
    Show/Hide
InChI
InChI=1S/C21H24N4/c1-2-4-17(5-3-1)14-20-15-23-24-21(20)19-8-12-25(13-9-19)16-18-6-10-22-11-7-18/h1-7,10-11,15,19H,8-9,12-14,16H2,(H,23,24)
    Show/Hide
InChIKey
DZLOTZYSSWSJCR-UHFFFAOYSA-N
Physicochemical Property
logP
3.7751
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
44.81
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56750906
ChEMBL ID
CHEMBL3608763
Table of Molecular Bioactivities Related to the Compound
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000393 HeLa-MAGI Homo sapiens (Human)  1
1
TC50 > 300000 nM
   TI
   LI
   LO
   TS
CL000752 PBMC iPSC #1 Homo sapiens (Human)  1
1
TC50 > 100000 nM
   TI
   LI
   LO
   TS